Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of topical NSAIDs for nonspecific low back pain
ChiCTR2300071919Phase 4Not yet recruiting
- Sponsor
- Xiamen University Zhongshan Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of loxoprofen in lumbodynia (LBP) (2 arms), sponsored by Xiamen University Zhongshan Hospital. Primary endpoint: Total response rate. Planned start May 2023; status: not yet recruiting.
02
Drugs
loxoprofen
03
Conditions
lumbodynia (LBP)
Beyond the preview
Go deeper on ChiCTR2300071919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071919.